Answer: C) Haemophilus influenzae
The correct answer is C) Haemophilus influenzae, as this is NOT a typical intracellular pathogen of concern in patients on TNF inhibitor therapy.
Rationale
TNF inhibitors impair cell-mediated immunity, which specifically increases vulnerability to intracellular pathogens. The question asks which organism is NOT a potential cause of infection in this immunocompromised state.
Why Haemophilus influenzae is the correct answer:
Haemophilus influenzae is an extracellular encapsulated bacterium, not an intracellular pathogen. While patients on immunosuppression may have increased susceptibility to encapsulated organisms, this is primarily related to humoral immunity defects (B-cell/antibody dysfunction), not the cell-mediated immunity impairment caused by TNF inhibitors.
Why the other options ARE intracellular pathogens at risk:
A) Listeria monocytogenes - This is explicitly highlighted as a major concern. The ECCO guidelines specifically state that anti-TNF agents confer a particularly high risk for serious L. monocytogenes infection, causing severe septicemia and meningitis with considerable mortality 1. The incidence appears higher with anti-TNF agents compared to other immunosuppressants 1.
B) Mycobacterium tuberculosis - The guidelines clearly identify that fungal and mycobacterial infections are specifically associated with anti-TNF agents 1. This is a well-established intracellular pathogen risk with TNF inhibitor therapy.
D) Cytomegalovirus - The guidelines note that viral infections are associated with thiopurines, and while not specifically highlighted for TNF inhibitors alone, CMV remains an intracellular pathogen concern in immunosuppressed IBD patients, particularly those on combination therapy 1.
Clinical Context
The ECCO guidelines emphasize that specific immunosuppressive medications are associated with different infection patterns: fungal and mycobacterial infections with anti-TNF agents, viral infections with thiopurines, and fungal infections (Candida) with corticosteroids 1. The common thread for TNF inhibitor-specific risk is intracellular pathogens that require intact cell-mediated immunity for control.
Common pitfall: Confusing general infection risk in immunosuppressed patients with the specific pattern of intracellular pathogen vulnerability caused by TNF inhibitor-induced impairment of cell-mediated immunity. Haemophilus influenzae, being extracellular, does not fit this mechanistic pattern.